We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+10.92%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$43.9B
AUM Growth
+$2.87B
(+7%)
Cap. Flow
-$890M
Cap. Flow
% of AUM
-2.03%
Top 10 Holdings %
Top 10 Hldgs %
13.25%
Holding
2,343
New
170
Increased
997
Reduced
1,015
Closed
150
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$111M |
| 2 |
Verizon
VZ
|
+$103M |
| 3 |
AT&T
T
|
+$103M |
| 4 |
Kroger
KR
|
+$97.1M |
| 5 |
3M
MMM
|
+$92.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$138M |
| 2 |
Tesla
TSLA
|
+$110M |
| 3 |
JPMorgan Chase
JPM
|
+$103M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$89.4M |
| 5 |
Apple
AAPL
|
+$85.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 16.25% |
| 3 | Financials | 11.85% |
| 4 | Industrials | 11.44% |
| 5 | Consumer Discretionary | 10.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
iHeartMedia
IHRT
$455M
| $1.69M | ﹤0.01% |
275,987
+88,589
| +47% | +$682K |
|
1327
Clarus
CLAR
$146M
| $1.69M | ﹤0.01% |
+215,621
| New | +$2.1M |
|
1328
ACM Research
ACMR
$5.57B
| $1.69M | ﹤0.01% |
+219,033
| New | +$1.86M |
|
|
TWNK
1329
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $1.69M | ﹤0.01% |
75,202
-66
| -0.1% | -$1.66K |
|
1330
Celsius Holdings
CELH
$7.11B
| $1.68M | ﹤0.01% |
49,704
-43,845
| -47% | -$1.43M |
|
1331
Healthcare Services Group
HCSG
$1.44B
| $1.68M | ﹤0.01% |
139,965
+71,034
| +103% | +$938K |
|
1332
Integer Holdings
ITGR
$4.25B
| $1.68M | ﹤0.01% |
24,531
+5,336
| +28% | +$349K |
|
|
CIR
1333
DELISTED
CIRCOR International, Inc
CIR
| $1.67M | ﹤0.01% |
69,850
-63,032
| -47% | -$1.41M |
|
1334
Zebra Technologies
ZBRA
$18.1B
| $1.67M | ﹤0.01% |
6,566
-14,115
| -68% | -$3.65M |
|
1335
Selective Insurance
SIGI
$5.6B
| $1.67M | ﹤0.01% |
18,846
-953
| -5% | -$86.9K |
|
1336
Patterson-UTI
PTEN
$4.22B
| $1.66M | ﹤0.01% |
98,658
-17,002
| -15% | -$281K |
|
1337
Alector
ALEC
$233M
| $1.66M | ﹤0.01% |
179,668
-476,360
| -73% | -$4.15M |
|
1338
Avery Dennison
AVY
$13.6B
| $1.66M | ﹤0.01% |
9,199
-2,139
| -19% | -$381K |
|
1339
Victory Capital Holdings
VCTR
$6.99B
| $1.65M | ﹤0.01% |
61,594
+11,141
| +22% | +$313K |
|
|
AXON
1340
Axon Enterprise
AXON
$51.7B
| $1.65M | ﹤0.01% |
10,085
-2,761
| -21% | -$436K |
|
1341
Turning Point Brands
TPB
$1.77B
| $1.65M | ﹤0.01% |
76,116
-1,025
| -1% | -$21.8K |
|
|
CVE.WS
1342
DELISTED
Cenovus Energy Inc Warrants
CVE.WS
| $1.64M | ﹤0.01% |
112,828
| – | – |
|
1343
Old National Bancorp
ONB
$10.3B
| $1.64M | ﹤0.01% |
91,148
-5,499
| -6% | -$101K |
|
1344
WesBanco
WSBC
$4.05B
| $1.63M | ﹤0.01% |
44,206
+4,604
| +12% | +$177K |
|
1345
ePlus
PLUS
$2.32B
| $1.63M | ﹤0.01% |
36,876
+3,155
| +9% | +$147K |
|
|
BIG
1346
DELISTED
Big Lots, Inc.
BIG
| $1.63M | ﹤0.01% |
+110,858
| New | +$1.91M |
|
1347
C4 Therapeutics
CCCC
$476M
| $1.62M | ﹤0.01% |
275,092
+182,924
| +198% | +$1.52M |
|
1348
Nasdaq
NDAQ
$53.1B
| $1.62M | ﹤0.01% |
26,405
-2,992
| -10% | -$186K |
|
|
SVC
1349
Service Properties Trust
SVC
$1.05B
| $1.61M | ﹤0.01% |
44,470
-55,602
| -56% | -$2.04M |
|
1350
Cimpress
CMPR
$2.32B
| $1.61M | ﹤0.01% |
58,144
-17,543
| -23% | -$455K |
|
Similar funds
VGA
AQR Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, AQR Capital Management held 2,343 positions worth $43.9B, up 7% from $41B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
AQR Capital Management's Q4 2022 filing shows 170 new, 997 increased, 1,015 reduced and 150 closed positions. Its largest new stake was Generac Holdings: 310,080 shares worth $30.5M. The largest sale was Gilead Sciences, an estimated $138M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q4 2022 buy was Generac Holdings: 310,080 shares worth $30.5M.
- AQR Capital Management added most to Humana in Q4 2022, an estimated $111M increase.
- AQR Capital Management's biggest Q4 2022 reduction was Gilead Sciences, cutting an estimated $138M.
- AQR Capital Management fully exited Abiomed Inc in Q4 2022, selling an estimated $22.4M.
- AQR Capital Management's ten largest holdings make up 13% of its $43.9B portfolio in Q4 2022.
- AQR Capital Management opened 170 new positions and closed 150 in Q4 2022.
- AQR Capital Management's portfolio value rose 7% quarter-over-quarter to $43.9B.
Based on AQR Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.